[{"uuid": "ec523b19-4431-38bd-b1bd-cdad39aa9e39", "title": "Aditxt\u2019s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/aditxt-board-directors-unanimously-approve-131500439.html", "providerPublishTime": 1736774100, "type": "STORY", "relatedTickers": ["ADTX"]}, {"uuid": "8479943a-f965-3d68-be3f-50f2e04bde52", "title": "Aditxt's Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic ADI Platform, Advancing Toward First-in-Human Clinical Trials", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/aditxts-subsidiary-adimune-successfully-completes-131500033.html", "providerPublishTime": 1734009300, "type": "STORY", "relatedTickers": ["APLIF", "ADTX", "EVFM"]}, {"uuid": "a1addbbd-39c6-3db5-bc23-85d2433547fb", "title": "Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/aditxt-acquisition-target-evofem-biosciences-133000977.html", "providerPublishTime": 1730899800, "type": "STORY", "relatedTickers": ["APLIF", "ADTX", "EVFM"]}, {"uuid": "3857c85d-0e01-390c-95ca-95c657e642f8", "title": "Aditxt\u2019s Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/aditxt-target-acquisition-appili-therapeutics-133000987.html", "providerPublishTime": 1730986200, "type": "STORY", "relatedTickers": ["APLIF", "ADTX"]}, {"uuid": "e08e8f5b-e80a-31ea-b27b-d47616d4495d", "title": "Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/aditxt-provides-equity-line-credit-133000035.html", "providerPublishTime": 1731072600, "type": "STORY", "relatedTickers": ["APLIF", "ADTX", "EVFM"]}, {"uuid": "5dda6bb5-d11d-3537-a3fc-27205f2fd5d0", "title": "Evofem Secures Investor Support for Proposed Merger through Voting Agreements", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/evofem-secures-investor-support-proposed-130000055.html", "providerPublishTime": 1730898000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/8iq5QhCszE.OfIG1XpFn.g--~B/aD0yMDk7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b0b393f2cbffee7b6c52a7dea7c44bd2", "width": 400, "height": 209, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/207dU_CH26YAZ2B.lHrd1A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/b0b393f2cbffee7b6c52a7dea7c44bd2", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EVFM", "ADTX"]}, {"uuid": "cb563c0f-5e9e-3a37-901b-0b911227b974", "title": "Evofem Biosciences Announces Financial Results for the Third Quarter of 2024", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/evofem-biosciences-announces-financial-results-213600668.html", "providerPublishTime": 1731620160, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/8iq5QhCszE.OfIG1XpFn.g--~B/aD0yMDk7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b0b393f2cbffee7b6c52a7dea7c44bd2", "width": 400, "height": 209, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/207dU_CH26YAZ2B.lHrd1A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/b0b393f2cbffee7b6c52a7dea7c44bd2", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EVFM", "ADTX"]}, {"uuid": "4f0cb709-f3f4-3e2f-8fec-cc270b47d872", "title": "Appili Therapeutics Announces Receipt of Final Court Order for Arrangement with Aditxt, Inc.", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/appili-therapeutics-announces-receipt-final-121700946.html", "providerPublishTime": 1732018620, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ZVv0R9LcLHrYKNbhKuRauw--~B/aD02MTt3PTE3NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/05d1cfb96c86bf2177fc4e5f1b3dccc1", "width": 174, "height": 61, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/JgwzN8PZsb5C2LxyQd_U4g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/05d1cfb96c86bf2177fc4e5f1b3dccc1", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["APLIF", "ADTX"]}, {"uuid": "2e2d471a-3d72-37a3-a194-6c353b65259e", "title": "Appili Therapeutics Announces Results of Special Meeting of Shareholders", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/appili-therapeutics-announces-results-special-225500372.html", "providerPublishTime": 1730933700, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ZVv0R9LcLHrYKNbhKuRauw--~B/aD02MTt3PTE3NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/05d1cfb96c86bf2177fc4e5f1b3dccc1", "width": 174, "height": 61, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/JgwzN8PZsb5C2LxyQd_U4g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/05d1cfb96c86bf2177fc4e5f1b3dccc1", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["APLIF", "ADTX"]}, {"uuid": "839c33ae-756a-38ab-8458-7d49e2aff082", "title": "Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/appili-therapeutics-reports-financial-operational-121500788.html", "providerPublishTime": 1731586500, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ZVv0R9LcLHrYKNbhKuRauw--~B/aD02MTt3PTE3NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/05d1cfb96c86bf2177fc4e5f1b3dccc1", "width": 174, "height": 61, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/JgwzN8PZsb5C2LxyQd_U4g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/05d1cfb96c86bf2177fc4e5f1b3dccc1", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["APLIF", "ADTX"]}]